{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:53:40Z","timestamp":1768593220402,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s11655-025-4212-3","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T06:31:16Z","timestamp":1750746676000},"page":"581-589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glucocorticoid Discontinuation in Patients with Rheumatoid Arthritis under Background of Chinese Medicine: Challenges and Potentials Coexist"],"prefix":"10.1007","volume":"31","author":[{"given":"Chuan-hui","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-ge","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong-min","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xie-li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-po","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang-yun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-yi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-lan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-juan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-fei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-ping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-ping","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"4212_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/rheumatology\/38.1.6","volume":"38","author":"RF Laan","year":"1999","unstructured":"Laan RF, Jansen TL, van Riel PL. Glucocorticosteroids in the management of rheumatoid arthritis. Rheumatology (Oxford) 1999;38:6\u201312.","journal-title":"Rheumatology (Oxford)"},{"key":"4212_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11926-002-0068-z","volume":"4","author":"KG Saag","year":"2002","unstructured":"Saag KG. Glucocorticoid use in rheumatoid arthritis. Curr Rheumatol Rep 2002;4:218\u2013225.","journal-title":"Curr Rheumatol Rep"},{"key":"4212_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/ard-2023-224270","volume":"83","author":"L van Ouwerkerk","year":"2024","unstructured":"van Ouwerkerk L, Verschueren P, Boers M, Emery P, de Jong PHP, Landew\u00e9 RB, et al. Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Ann Rheum Dis 2024;83:65\u201371.","journal-title":"Ann Rheum Dis"},{"key":"4212_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/rheumatology\/keac355","volume":"62","author":"F Buttgereit","year":"2022","unstructured":"Buttgereit F, Kvien TK. Controversies in rheumatology: maintenance therapy with low-dose glucocorticoids in rheumatoid arthritis. Rheumatology (Oxford) 2022;62:35\u201341.","journal-title":"Rheumatology (Oxford)"},{"key":"4212_CR5","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo A, Bathon JM, Emery P. Rheumatoid arthritis. Lancet 2023;402:2019\u20132033.","journal-title":"Lancet"},{"key":"4212_CR6","doi-asserted-by":"publisher","first-page":"e000536","DOI":"10.1136\/rmdopen-2017-000536","volume":"6","author":"C Hua","year":"2020","unstructured":"Hua C, Buttgereit F, Combe B. Glucocorticoids in rheumatoid arthritis: current status and future studies. RMD Open 2020;6:e000536.","journal-title":"RMD Open"},{"key":"4212_CR7","doi-asserted-by":"publisher","first-page":"870","DOI":"10.7326\/M20-1594","volume":"173","author":"MD George","year":"2020","unstructured":"George MD, Baker JF, Winthrop K, Hsu JY, Wu QF, Chen L, et al. Risk for serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis:a cohort study. Ann Intern Med 2020;173:870\u2013878.","journal-title":"Ann Intern Med"},{"key":"4212_CR8","first-page":"12271","volume":"365","author":"E Mahase","year":"2019","unstructured":"Mahase E. Rheumatoid arthritis: glucocorticoids are associated with nearly double infection risk post-surgery. BMJ 2019;365:12271.","journal-title":"BMJ"},{"key":"4212_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/art.38210","volume":"66","author":"I del Rinc\u00f3n","year":"2014","unstructured":"del Rinc\u00f3n I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol 2014;66:264\u2013272.","journal-title":"Arthritis Rheumatol"},{"key":"4212_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/ard-2022-223358","volume":"82","author":"SA Bergstra","year":"2023","unstructured":"Bergstra SA, Sepriano A, Kerschbaumer A, van der Heijde D, Caporali R, Edwards CJ, et al. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2023;82:81\u201394.","journal-title":"Ann Rheum Dis"},{"key":"4212_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"JS Smolen","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 2023;82:3\u201318.","journal-title":"Ann Rheum Dis"},{"key":"4212_CR12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/art.42507","volume":"75","author":"BR England","year":"2023","unstructured":"England BR, Smith BJ, Baker NA, Barton JL, Oatis CA, Guyatt G, et al. 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis. Arthritis Rheumatol 2023;75:1299\u20131311.","journal-title":"Arthritis Rheumatol"},{"key":"4212_CR13","doi-asserted-by":"publisher","first-page":"152219","DOI":"10.1016\/j.semarthrit.2023.152219","volume":"61","author":"LP Crowson","year":"2023","unstructured":"Crowson LP, Davis JM, Hanson AC, Myasoedova E, Kronzer VL, Makol A, et al. Time trends in glucocorticoid use in rheumatoid arthritis during the biologics era: 1999\u20132018. Semin Arthritis Rheum 2023;61:152219.","journal-title":"Semin Arthritis Rheum"},{"key":"4212_CR14","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00296-021-04939-8","volume":"41","author":"B Yagiz","year":"2021","unstructured":"Yagiz B, Coskun BN, Pehlivan Y, Dalkilic E, Kiraz S, Yazisiz V, et al. In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids? Rheumatol Int 2021;41:1915\u20131924.","journal-title":"Rheumatol Int"},{"key":"4212_CR15","first-page":"63","volume-title":"Rheumatoid arthritis in China: a national report of 2020","author":"XF Zeng","year":"2021","unstructured":"Zeng XF, Tian XP, Li MT. Rheumatoid arthritis in China: a national report of 2020. 1st ed. Beijing: Liaoning Science and Technology Press;2021:63\u201366.","edition":"1st ed"},{"key":"4212_CR16","doi-asserted-by":"publisher","first-page":"153921","DOI":"10.1016\/j.phymed.2021.153921","volume":"98","author":"Z Dai","year":"2022","unstructured":"Dai Z, Liao X, Wieland LS, Hu J, Wang YY, Kim TH, et al. Cochrane systematic reviews on traditional Chinese medicine: what matters\u2014the quantity or quality of evidence? Phytomedicine 2022;98:153921.","journal-title":"Phytomedicine"},{"key":"4212_CR17","doi-asserted-by":"publisher","first-page":"679588","DOI":"10.3389\/fphar.2021.679588","volume":"12","author":"X Gong","year":"2021","unstructured":"Gong X, Liu WX, Tang XP, Wang J, Liu J, Huang QC, et al. Traditional Chinese medicine Qingre Huoxue treatment vs. the combination of methotrexate and hydroxychloroquine for active rheumatoid arthritis: a multicenter, double-blind, randomized controlled trial. Front Pharmacol 2021;12:679588.","journal-title":"Front Pharmacol"},{"key":"4212_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13020-020-00319-9","volume":"15","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wu JQ, Li DY, Tang X, Zhao Y, Cai X, et al. Traditional Chinese medicine Biqi Capsule compared with leflunomide in combination with methotrexate in patients with rheumatoid arthritis: a randomized controlled trial. Chin Med 2020;15:36.","journal-title":"Chin Med"},{"key":"4212_CR19","doi-asserted-by":"publisher","first-page":"116782","DOI":"10.1016\/j.jep.2023.116782","volume":"317","author":"L Zhang","year":"2023","unstructured":"Zhang L, Jiang SQ, Guan ZH, Huang JY, Yin ZK, Tan GY, et al. Effect of Salvia miltiorrhiza Bunge extracts on improving the efficacy and reducing the toxicity of Tripterygium wilfordii polyglycosides in the treatment of rheumatoid arthritis. J Ethnopharmacol 2023;317:116782.","journal-title":"J Ethnopharmacol"},{"key":"4212_CR20","doi-asserted-by":"publisher","first-page":"154236","DOI":"10.1016\/j.phymed.2022.154236","volume":"104","author":"X Gong","year":"2022","unstructured":"Gong X, Liu WX, Li D, Peng QW, Xia CM, Chang T, et al. China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): rationale, design, and baseline characteristics of the first 11,764 enrollees. Phytomedicine 2022;104:154236.","journal-title":"Phytomedicine"},{"key":"4212_CR21","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, David TF, Clifton OB, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569\u20132581.","journal-title":"Arthritis Rheum"},{"key":"4212_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/art.1780360601","volume":"36","author":"DT Felson","year":"1993","unstructured":"Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729\u2013740.","journal-title":"Arthritis Rheum"},{"key":"4212_CR23","first-page":"958","volume":"34","author":"JD Carter","year":"2007","unstructured":"Carter JD, Lodhi AB, Nagda SR, Ricca L, Ward C, Traina E, et al. Determining rheumatologists\u2019 accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index. J Rheumatol 2007;34:958\u2013963.","journal-title":"J Rheumatol"},{"key":"4212_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van Thof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44\u201348.","journal-title":"Arthritis Rheum"},{"key":"4212_CR25","first-page":"S100","volume":"23","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005;23:S100\u2013S108.","journal-title":"Clin Exp Rheumatol"},{"key":"4212_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/BOR.0000000000000278","volume":"28","author":"MC van der Goes","year":"2016","unstructured":"van der Goes MC, Jacobs JWG, Bijlsma JWJ. Rediscovering the therapeutic use of glucocorticoids in rheumatoid arthritis. Curr Opin Rheumatol 2016;28:289\u2013296.","journal-title":"Curr Opin Rheumatol"},{"key":"4212_CR27","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","volume":"75","author":"C Strehl","year":"2016","unstructured":"Strehl C, Bijlsma JWJ, de Wit M, Boers M, Caeyers N, Cutolo M, et al. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Ann Rheum Dis 2016;75:952\u2013957.","journal-title":"Ann Rheum Dis"},{"key":"4212_CR28","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1136\/annrheumdis-2016-210135","volume":"76","author":"C Roubille","year":"2017","unstructured":"Roubille C, Rincheval N, Dougados M, Flipo RM, Daur\u00e8s JP, Combe B. Seven-year tolerability profile of glucocorticoids use in early rheumatoid arthritis: data from the ESPOIR cohort. Ann Rheum Dis 2017;76:1797\u20131802.","journal-title":"Ann Rheum Dis"},{"key":"4212_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1136\/annrheumdis-2016-209954","volume":"76","author":"G Ozen","year":"2017","unstructured":"Ozen G, Pedro S, Holmqvist ME, Avery M, Wolfe F, Michaud K. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis. Ann Rheum Dis 2017;76:848\u2013854.","journal-title":"Ann Rheum Dis"},{"key":"4212_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40744-018-0093-7","volume":"5","author":"R Fleischmann","year":"2018","unstructured":"Fleischmann R, Wollenhaupt J, Cohen S, Wang L, Fan H, Bandi V, et al. Effect of discontinuation or initiation of methotrexate or glucocorticoids on tofacitinib efficacy in patients with rheumatoid arthritis: a post hoc analysis. Rheumatol Ther 2018;5:203\u2013214.","journal-title":"Rheumatol Ther"},{"key":"4212_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/annrheumdis-2021-220112","volume":"80","author":"WH Xie","year":"2021","unstructured":"Xie WH, Huang H, Li GT, Hao YJ, Gui YN, Wang Y, et al. Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020. Ann Rheum Dis 2021;80:997\u20131003.","journal-title":"Ann Rheum Dis"},{"key":"4212_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.intimp.2016.10.005","volume":"41","author":"YL Yang","year":"2016","unstructured":"Yang YL, Ye YJ, Qiu Q, Xiao Y, J Huang MC, Shi MH, et al. Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway. Int Immunopharmacol 2016;41:8\u201316.","journal-title":"Int Immunopharmacol"},{"key":"4212_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jconrel.2022.05.016","volume":"348","author":"Y Lin","year":"2022","unstructured":"Lin Y, Yi OY, Hu MY, Hu ST, Su ZL, Liao J, et al. Multifunctional nanoparticles of sinomenine hydrochloride for treat-to-target therapy of rheumatoid arthritis via modulation of proinflammatory cytokines. J Control Release 2022;348:42\u201356.","journal-title":"J Control Release"},{"key":"4212_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40744-022-00527-9","volume":"10","author":"WH Xie","year":"2023","unstructured":"Xie WH, Huang H, Zhang ZL. Dynamic characteristics and predictive profile of glucocorticoids withdrawal in rheumatoid arthritis patients commencing glucocorticoids with csDMARD: a real-world experience. Rheumatol Ther 2023;10:405\u2013419.","journal-title":"Rheumatol Ther"},{"key":"4212_CR35","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/1756-185X.13651","volume":"22","author":"WH Xie","year":"2019","unstructured":"Xie WH, Li J, Zhang XH, Sun XY, Zhang ZL. Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018. Int J Rheum Dis 2019;22:1670\u20131678.","journal-title":"Int J Rheum Dis"},{"key":"4212_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13075-017-1484-9","volume":"20","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Szumski A, Koenig AS, Jones TV, Marshall L. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial. Arthritis Res Ther 2018;20:8.","journal-title":"Arthritis Res Ther"},{"key":"4212_CR37","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/rheumatology\/keg355","volume":"42","author":"E Morrison","year":"2003","unstructured":"Morrison E, Crosbie D, Capell HA. Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids. Rheumatology (Oxford) 2003;42:1247\u20131250.","journal-title":"Rheumatology (Oxford)"},{"key":"4212_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semarthrit.2019.06.003","volume":"49","author":"RJ Black","year":"2019","unstructured":"Black RJ, Richards B, Lester S, Buchbinder R, Barrett C, Lassere M, et al. Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis. Semin Arthritis Rheum 2019;49:351\u2013357.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-025-4212-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T18:02:56Z","timestamp":1750788176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-025-4212-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1007\/s11655-025-4212-3","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"14 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}